New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma

Abstract Medulloblastoma (MB), the most prevalent brain malignancy in children, presents significant challenges in paediatric oncology due to its aggressiveness and potential for relapse. Tailored treatments are crucial to mitigate treatment-related toxicities and long-term side effects on developin...

Full description

Saved in:
Bibliographic Details
Main Authors: Denis Mustafov, Laura Thomas, Shoib S. Siddiqui, George I. Lambrou, Maria Braoudaki
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-05517-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238563542007808
author Denis Mustafov
Laura Thomas
Shoib S. Siddiqui
George I. Lambrou
Maria Braoudaki
author_facet Denis Mustafov
Laura Thomas
Shoib S. Siddiqui
George I. Lambrou
Maria Braoudaki
author_sort Denis Mustafov
collection DOAJ
description Abstract Medulloblastoma (MB), the most prevalent brain malignancy in children, presents significant challenges in paediatric oncology due to its aggressiveness and potential for relapse. Tailored treatments are crucial to mitigate treatment-related toxicities and long-term side effects on developing brains. Our study aimed to identify therapeutic targets for paediatric MB and explore common miRNA biosignatures with glioblastoma (GB), the most aggressive adult brain tumour. High-throughput small-RNA sequencing identified miR-206 and miR-383 as highly downregulated in MB samples, suggesting their tumour suppressor properties. Bioinformatics analysis identified CORO1C and SV2B as their targets. RT-qPCR, western blotting, and immunohistochemistry confirmed their overexpression in MB and GB. Elevated CORO1C expression was also found in adult MB and GB tissue samples. The role of both miRNAs on their target genes was validated through in vitro functional assays. Our study uncovers the potential role of miR-206/CORO1C and miR-383/SV2B axes as innovative therapeutic targets for combating aggressive paediatric and adult brain malignancies.
format Article
id doaj-art-a8f2dafff1dd4a78943b73eaccce8734
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a8f2dafff1dd4a78943b73eaccce87342025-08-20T04:01:34ZengNature PortfolioScientific Reports2045-23222025-07-0115111810.1038/s41598-025-05517-9New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastomaDenis Mustafov0Laura Thomas1Shoib S. Siddiqui2George I. Lambrou3Maria Braoudaki4School of Health, Medicine and Life Sciences, University of HertfordshireSchool of Health, Medicine and Life Sciences, University of HertfordshireSchool of Health, Medicine and Life Sciences, University of HertfordshireChoremeio Research Laboratory, First Department of Pediatrics, School of Medicine, National and Kapodistrian University of AthensSchool of Health, Medicine and Life Sciences, University of HertfordshireAbstract Medulloblastoma (MB), the most prevalent brain malignancy in children, presents significant challenges in paediatric oncology due to its aggressiveness and potential for relapse. Tailored treatments are crucial to mitigate treatment-related toxicities and long-term side effects on developing brains. Our study aimed to identify therapeutic targets for paediatric MB and explore common miRNA biosignatures with glioblastoma (GB), the most aggressive adult brain tumour. High-throughput small-RNA sequencing identified miR-206 and miR-383 as highly downregulated in MB samples, suggesting their tumour suppressor properties. Bioinformatics analysis identified CORO1C and SV2B as their targets. RT-qPCR, western blotting, and immunohistochemistry confirmed their overexpression in MB and GB. Elevated CORO1C expression was also found in adult MB and GB tissue samples. The role of both miRNAs on their target genes was validated through in vitro functional assays. Our study uncovers the potential role of miR-206/CORO1C and miR-383/SV2B axes as innovative therapeutic targets for combating aggressive paediatric and adult brain malignancies.https://doi.org/10.1038/s41598-025-05517-9
spellingShingle Denis Mustafov
Laura Thomas
Shoib S. Siddiqui
George I. Lambrou
Maria Braoudaki
New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
Scientific Reports
title New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
title_full New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
title_fullStr New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
title_full_unstemmed New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
title_short New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
title_sort new microrna based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
url https://doi.org/10.1038/s41598-025-05517-9
work_keys_str_mv AT denismustafov newmicrornabasedtherapiesrevealcommontargetsinpaediatricmedulloblastomaandadultglioblastoma
AT laurathomas newmicrornabasedtherapiesrevealcommontargetsinpaediatricmedulloblastomaandadultglioblastoma
AT shoibssiddiqui newmicrornabasedtherapiesrevealcommontargetsinpaediatricmedulloblastomaandadultglioblastoma
AT georgeilambrou newmicrornabasedtherapiesrevealcommontargetsinpaediatricmedulloblastomaandadultglioblastoma
AT mariabraoudaki newmicrornabasedtherapiesrevealcommontargetsinpaediatricmedulloblastomaandadultglioblastoma